Basic Information
ID: ALA1931089
Type: Functional
Description: Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as inhibition of virus induced-plaque formation after 3 days by neutral red-based plaque reduction assay
Organism: Human rhinovirus 1B
Cell type: HeLa
Activity Charts
Bioactivity
Activity Types for Assay ALA1931089
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 279.17 | 5.06 | 5.06 |
| 262.31 | 3.90 | 3.90 |
| 296.75 | 4.55 | 4.55 |
| 331.20 | 5.21 | 5.21 |
| 296.75 | 4.55 | 4.55 |
| 280.30 | 4.04 | 4.04 |
| 260.29 | 3.24 | 3.24 |
| 294.74 | 3.89 | 3.89 |
| 248.33 | 4.26 | 4.26 |
| 282.77 | 4.91 | 4.91 |
| 317.22 | 5.57 | 5.57 |
| 282.77 | 4.91 | 4.91 |
| 266.32 | 4.40 | 4.40 |
| 248.32 | 4.26 | 4.26 |
| 282.77 | 4.91 | 4.91 |
| 317.22 | 5.57 | 5.57 |
| 282.77 | 4.91 | 4.91 |